Related Experiment Video
Updated: Apr 16, 2026

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Evaluation of histologic features with potential prognostic value in ulcerative colitis
This study found that basal plasmacytosis in ulcerative colitis (UC) biopsies is a strong indicator of disease prognosis. This highlights the importance of detailed histologic analysis for predicting UC patient outcomes and relapse risk.
Area of Science:
- Gastroenterology
- Pathology
- Internal Medicine
Background:
- Inflammatory bowel diseases (IBD) encompass conditions like ulcerative colitis (UC) and Crohn's disease (CD).
- Ulcerative colitis is a common form of IBD, characterized by chronic inflammation of the colon.
- Understanding UC's evolution and outcome is crucial for patient management.
Purpose of the Study:
- To evaluate the impact of specific histologic features on the evolution and outcome of ulcerative colitis.
- To correlate clinical and endoscopic disease activity (Mayo score) with histologic findings.
Main Methods:
- A cohort of 20 UC patients underwent prospective clinical, biochemical, endoscopic, and histologic surveillance.
- Ileo-colonoscopies with biopsies were performed at baseline and after 12 months.
- Pearson correlation tested the association between Mayo score and histologic features (Geboes score, basal plasmacytosis, vascular lesions).
Main Results:
- Basal plasmacytosis demonstrated the most promising prognostic value in ulcerative colitis.
- Correlation analysis identified specific histologic features associated with UC activity and outcome.
- The study confirms previous findings regarding the prognostic significance of basal plasmacytosis.
Conclusions:
- Basal plasmacytosis is a key histologic feature for predicting ulcerative colitis prognosis.
- A comprehensive assessment system integrating clinical, endoscopic, and histologic data is needed.
- Stratifying UC patients by risk of relapse can be improved through detailed semi-quantitative analysis.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Histology of the Small Intestine
The intestinal lining features transverse folds called circular folds, each housing fingerlike projections known as intestinal villi. These villi are covered by a layer of simple columnar epithelium, also referred to as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

